More evidence against hydroxychloroquine as COVID-19 therapy
A US observational study suggests it neither helps nor harms
Hydroxychloroquine has again failed to show a benefit in patients hospitalised with COVID-19, according to an observational study.
In the US study, 811 patients with COVID-19 received hydroxychloroquine while 565 did not, the authors reported in the New England Journal of Medicine.
